[18F]-PE2I
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for [18F]-PE2I, covering 2025-02-06 to 2025-02-06. Get the full timeline:
Most recent: Clinical Trial Update: [18F]-MFBG Versus [123I]-MIBG and [18F]-PE2I in PD vs. MSA and DLB vs. AD [Phase 2, Phase 3]